Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies

Area of Science:

• Endocrinology
• Oncology
• Molecular Biology

Background:

• Growth hormone (GH) is essential for growth but also implicated in cancer development.
• Abnormal GH secretion causes GH deficiency (GHD) and acromegaly.
• GH can act as an endocrine hormone or a local autocrine/paracrine growth factor.

Purpose of the Study:

• To distinguish the roles of endocrine vs. autocrine/paracrine GH in cancer promotion.
• To reconcile discrepancies between experimental and clinical data on GH and cancer.
• To evaluate the potential of targeting GH action in cancer therapy.

Main Methods:

• Review of existing literature on GH, cancer, and related pathologies.
• Analysis of epidemiological, clinical, and experimental studies.
• Detailed examination of molecular mechanisms linking GH to tumor circuitry.

Main Results:

• GH is implicated in various cancer-associated events, both locally and systemically.
• Evidence suggests GH acts as a critical node in tumor progression.
• Discrepancies exist between in vitro/in vivo studies and clinical observations regarding GH's role in cancer.

Conclusions:

• Differentiating GH's endocrine and autocrine/paracrine functions is crucial for understanding its role in cancer.
• Targeting GH action presents a promising therapeutic avenue for specific cancer patient subsets.
• Further research is needed to fully elucidate GH's complex relationship with cancer.